<DOC>
	<DOCNO>NCT02162576</DOCNO>
	<brief_summary>Propeller Health collaborate Walgreens Pharmacies , City Louisville , Qualcomm Life local partner carry focused demonstration project evaluate effectiveness Propeller Health approach asthma management explore mean use real-time data asthma exacerbation public health setting . The Asthma Data Innovation Demonstration Project ( ADID ) use wireless sensor technology develop spatial temporal data use rescue inhaler 300 study subject asthma Louisville metropolitan area . Propeller Health process data support two general strategy . Asthma self management : Rescue inhaler actuation data compile individualized feedback report support asthma self management . Propeller Health combine information individual rescue inhaler actuation evidence-based asthma management tip real-time report provide subject . ADID staff evaluate result improvement asthma control may base information . Subjects may share report healthcare provider . Municipal purpose : The second strategy provide aggregate de-identified , spatial temporal asthma rescue inhaler actuation data City personnel authorize public health researcher Louisville . These data show time location use rescue inhaler 300 study subject throughout great Louisville area . ADID staff work City personnel researcher investigate unprecedented level detail information exacerbation use best increase public awareness environmental trigger support public health surveillance effort around respiratory disease .</brief_summary>
	<brief_title>Asthma Data Innovation Demonstration Project</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Immune System Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Respiratory Tract Diseases</mesh_term>
	<mesh_term>Bronchial Diseases</mesh_term>
	<mesh_term>Hypersensitivity , Immediate</mesh_term>
	<mesh_term>Respiratory Hypersensitivity</mesh_term>
	<criteria>Selfreported provider diagnosis asthma Prescription Short Acting Beta Agonist ( SABA ) study intake Subject age 5 beginning study Subject speak English Subject access Internet email receive report Subject substantial comorbidity ( selfreported provider diagnosis COPD )</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>asthma</keyword>
	<keyword>asthma control</keyword>
	<keyword>healthcare utilization cost</keyword>
	<keyword>community hotspot</keyword>
	<keyword>public health research</keyword>
</DOC>